Next Financial Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Next Financial Group’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1K	Buy	+9	New	+$732	﹤0.01%	2791
2017 Q4	–	Sell	-65	Closed	-$4K	–	1129
2017 Q3	$4K	Sell	65 -50	-43%	-$2.96K	﹤0.01%	1498
2017 Q2	$7K	Hold	115	–	–	﹤0.01%	1456
2017 Q1	$7K	Hold	115	–	–	﹤0.01%	1411
2016 Q4	$8K	Buy	+115	New	+$8.16K	﹤0.01%	1759
2014 Q4	–	Sell	-900	Closed	-$51K	–	2266
2014 Q3	$51K	Buy	+900	New	+$45.3K	0.01%	937

Other funds holding RARE

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Next Financial Group's RARE Position: Q4 2021 in Review

Next Financial Group opened a new position in Ultragenyx Pharmaceutical (RARE) in Q4 2021: 9 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2791 among its holdings. This is a return to the name: Next Financial Group previously reported a position in RARE as recently as Q3 2017.

Next Financial Group first reported a position in RARE in Q3 2014 and has held it in 6 quarters since. The position peaked at $51K in Q3 2014. 234 funds tracked by Wall St. Rank hold RARE as of Q4 2021.

Next Financial Group held 9 shares of Ultragenyx Pharmaceutical worth $1K as of Q4 2021.
Ultragenyx Pharmaceutical was a new Next Financial Group position in Q4 2021.
Ultragenyx Pharmaceutical made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2791 holding.
Next Financial Group first reported a position in Ultragenyx Pharmaceutical in Q3 2014 and has held it in 6 quarters since.
Next Financial Group's Ultragenyx Pharmaceutical position peaked at $51K in Q3 2014.
234 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.